Brown, Landon C. http://orcid.org/0000-0002-5231-4859
Lu, Changxue
Antonarakis, Emmanuel S.
Luo, Jun
Armstrong, Andrew J. http://orcid.org/0000-0001-7012-1754
Article History
Received: 20 November 2019
Revised: 1 February 2020
Accepted: 11 February 2020
First Online: 24 February 2020
Compliance with ethical standards
:
: AJA has served as a paid consultant for Astrazeneca, Merck, Dendreon, Janssen, Clovis, Bayer, and Medivation/Astellas; is on the speaker’s bureau for Bayer and Dendreon; and receives research funding to his institution from Janssen, Medivation/Astellas, Sanofi-aventis, Active Biotech, Bayer, Dendreon, Merck, Astrazeneca, Genentech/Roche, BMS, Constellation, Novartis, and Pfizer. ESA has served as a paid consultant/advisor for Janssen, Pfizer, Sanofi, Dendreon, Essa, Merck, Bristol-Myers Squibb, AstraZeneca, Clovis, Eli Lilly and Amgen; has received research funding to his institution from Janssen, Johnson & Johnson, Sanofi, Dendreon, Genentech, Novartis, Tokai, Merck, Bristol-Myers Squibb, AstraZeneca and Constellation; and is a co-inventor of an AR-V7 biomarker technology that has been licensed to Qiagen. JL has served as a paid consultant/advisor for Sun Pharma, Janssen, Tolero, and Sanofi; has received research funding to his institution from Orion, Mirati, Astellas, Sanofi, Constellation, Calibr, Pandomedx, and Gilead; and is a co-inventor of a technology that has been licensed to Tokai, Qiagen, and A&G. CL is a co-inventor of a technology that has been licensed to Tokai and Qiagen.